🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Qara › Texas › Irving

Qorannoo klinikaalii Dhibee Qara Irving, TX keessatti

Qorannoo 6 Dhibee Qara f Irving fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Namoota walitti qabaa jiraSadarkaa 3
  • US Oncology Research Investigational Products Center, Irving
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05920356

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • US Oncology Investigational Products Center (IPC), Irving
  • US Oncology Investigational Products Center, Irving
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07222566

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • NEXT Oncology - Irving, Irving
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06618287

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • NEXT Dallas, Irving
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Namoota walitti qabaa jiraSadarkaa 1/2
  • NEXT Oncology Dallas, Irving
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06162221

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Namoota walitti qabaa jiraSadarkaa 1/2
  • NEXT Dallas, Irving
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Cam-2026 · NCT06922591

Qorannoo Dhibee Qara magaalota biroo keessatti

Qorannoo biroo Irving keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.